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A B S T R A C T
Scaffolds combining nano- and submicro-fibers closely mimicking extracellular matrix (ECM) have been poorly
exploited for in vitro cancer cell culture. Herein, a combined electrospinning and modified in situ biosynthesis
method has been developed to fabricate a novel scaffold consisting of bacterial cellulose (BC) nanofibers and
electrospun cellulose acetate (CA) submicrofibers to mimic the fibrillar structure of natural ECM. The CA/BC
nano/submicrofibrous scaffold was characterized by scanning electron microscopy (SEM), mechanical strength
tests, porosity measurements, and cell studies using the MCF-7 breast cancer cells. In addition, the sensitivity of
the cancer cells seeded in the CA/BC nano/submicrofibrous scaffold to an anticancer drug was assessed. It was
found that the CA/BC scaffold exhibited an interconnected porous structure in which BC nanofibers penetrated
into the submicrofibrous CA scaffold. Such sophisticated structure was responsible for the improved mechanical
properties of CA/BC scaffold over the ones obtained using a single kind of fibers. More importantly, the CA/BC
scaffold showed improved cell adhesion, migration, and proliferation over single BC or CA scaffold. Finally, cells
grown on CA/BC scaffold exhibited a greater doxorubicin resistance than those on single CA or BC scaffold. The
results suggest that the CA/BC nano/submicrofibrous scaffold has potential for application in in vitro tumor
model for the study of cancer progression and drug screening.
1. Introduction
Cancer affects millions of people worldwide and has become a
leading cause of death. Therefore, investigation on the formation, in-
vasion, metastasis of malignant tumor is of critical importance. In this
context, in vitro cancer models (analogous to scaffolds in tissue en-
gineering) that mimic the microenvironment where the cancerous cells
reside and the tumor develops are highly demanded. Such in vitro
cancer models have been proven effective in studying cancer patho-
genesis and development, anti-cancer mechanism, and drug testing
[1–4]. So far, numerous materials including gelatin, carbon nanotube,
collagen, fibrin, poly(lactic acid), poly(glycolic acid), poly(lactic-co-
glycolic acid), poly (ε-caprolactone), and others have been used to
construct in vitro cancer models [5–7]. In our previous studies, bacterial
cellulose (BC) was also used in light of its 3D network structure and, in
particular, its nano-scaled fiber diameter which is the lower limit of
natural ECM fibers [8,9]. This is desirable and necessary since both
chemical composition and scaffold architecture are important
parameters for in vitro cancer models. In tissue engineering, scaffolds
that bear structure similar to natural extracellular matrix (ECM) are
highly desirable since they can promote cell attachment and pro-
liferation and finally to promote new ECM growth [10]. In this context,
fibrous scaffolds that mimic natural tissues are widely studied due to
their ability to manipulate cell fate by providing topographical cues
[11,12]. In recent years, many researchers have agreed that it is ex-
tremely important to take into account of the multiscale organization of
the natural ECM, which is composed of fibers ranging from dozens to
hundreds of nanometers. Therefore, in designing new scaffolds for
tissue engineering, it is important to endow them with hierarchical
structure. Previously, multilayered hierarchical scaffolds were reported
[13–15]. However, some tissues such as cornea have an integrated
nano-micro-fibrous structure. Although many previous studies have
demonstrated that scaffolds for tissue engineering could be used for
tumor engineering [5,16–18], no report dealing with the hierarchical
interpenetrated fibrous scaffolds for tumor engineering can be found in
literature.
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In this work, we have prepared a novel hierarchical fibrous scaffold
with nano- and submicro-fibers by combining BC nanofibers with a
diameter smaller than 100 nm with submicrofibers of electrospun cel-
lulose acetate (CA) with a diameter of a few hundreds of nanometers for
potential applications in tumor engineering (as an in vitro cancer
model). The CA submicrofibrous scaffold was fabricated by electro-
spinning. The BC nanofibers were then totally impregnated into the
submicrofibrous CA scaffold using a modified in situ biosynthesis pro-
cess [19–21]. The resultant hierarchical fibrous CA/BC scaffold with
interpenetrated nano (ca. 49 nm) and submicron (ca. 780 nm) fibrous
structure was seeded with MCF-7 breast cancer cells to assess the
suitability of the hierarchical fibrous scaffold for potential application
as tumor engineering scaffolds. The purpose of this work was thus to
prepare and characterize the novel scaffold consisting of nanofibrous
BC and submicrofibrous CA and test the growth, adhesion, and pro-
liferation of the MCF-7 cells on the scaffold. As control, single BC na-
nofibrous scaffold and electrospun CA submicrofibrous scaffold were
also prepared and characterized. In addition, the antiproliferative effect
of a model anticancer drug (doxorubicin) on the cancer cells seeded on
various scaffolds was tested.
2. Materials and methods
2.1. Preparation of submicrofibrous CA scaffold by electrospinning
The submicrofibrous CA scaffold was prepared by electrospinning at
40% relative humidity and room temperature. The concentration of CA
solution was kept at 15 wt% which was obtained by dissolving 1.5 g of
CA (Mn=4.0×104 gmol−1, supplied by Shanghai Aladdin Bio-Chem
Technology Co. Ltd., Shanghai, China) into 10mL of acetone/acetic
acid mixture at a volume ratio of 1 : 1 under constant stirring. The
solution was fed into a plastic syringe (10mL) with a metal needle tip
which was driven by a syringe pump. The applied voltage was 10 kV,
the flow rate was 5mL/h, and the tip-to-collector distance was 15 cm.
The obtained CA scaffold was dried in vacuum oven at 80 °C for 24 h.
2.2. Preparation of nano-submicrofibrous CA/BC scaffold
To incorporate BC nanofibers into submicrofibrous CA scaffold, a
modified in situ biosynthesis method was applied [19–21] using the
bacterial strain Komagataeibacter xylinus X-2 and a culture medium
composed of 2.5% (w/v) glucose, 0.75% (w/v) yeast extract, 1% (w/v)
tryptone, and 1% (w/v) Na2HPO4 [22–25]. Firstly, a BC pellicle with a
thickness of 3mm was prepared by conventional static culture method
and used as the substrate on which submicrofibrous scaffold was
placed. Secondly, the atomized culture medium was deposited onto the
CA scaffold followed by in situ BC growth within the CA scaffold. After
BC growth, the atomizing and growing was repeated up to the fifth
cycle, each one taking around 6 h. Finally, the harvested CA/BC scaf-
fold (after removing BC substrate) was purified by soaking in deionized
water at 90 °C for 2 h, boiling in a 0.5M NaOH solution for 15min to
remove residual bacteria within BC network, and thorough washing
with abundant deionized water. The CA/BC hydrogel was then im-
mersed in tertiary butanol which was renewed 3 to 4 times to remove
deionized water followed by freeze drying at −20 °C for 12 h, and fi-
nally lyophilized at −50 °C for 24 h, yielding CA/BC scaffold. The re-
sultant CA/BC scaffold had a BC weight content of ca. 12%. As control,
a bare BC scaffold was also prepared by the same procedure.
2.3. Characterization
Morphology of the scaffolds was investigated using a FEI Nano 430
scanning electron microscope (SEM). The fiber diameter and the
average pore sizes were measured and averaged using the Nano
Measure1.2 software by randomly selecting at least 100 fiber segments
and pores, respectively [21,26,27].
Water contact angles of BC, CA, and BC/CA materials (after pressing
at room temperature) were measured with a contact angle meter (Drop
Master 300).
Porosity of the scaffolds was measured by the liquid displacement














where Wa represents the weight of the specific gravity bottle filled with
ethanol, Wb is the weight of the specific gravity bottle filled with
ethanol and scaffold, andWc denotes the weight of the specific gravity
bottle after subtracting the weight of the scaffold from Wb; Wi is the
initial weight of the scaffold and ρe denotes the density of ethanol
(0.8 g cm−3).
Tensile properties were tested using a micro-electromagnetic fatigue
testing machine (MUF-1050, Tianjin Care Measure & Control Co., Ltd.,
Tianjin, China) and the specimen dimensions were 10×5×2mm3.
The measurement was carried out at a strain rate of 5mmmin−1 and
repeated at least five times.
2.4. Cell studies
2.4.1. Cell culture and seeding on scaffolds
The MCF-7 breast cancer cells used in this work were obtained from
Shanghai cell bank, Chinese Academy of Sciences. After being passaged
to the sixth generation, the MCF-7 cells were cultured in dulbecco's
modified eagle medium (DMEM, Hyclone, America) supplemented with
10% fetal bovine serum (Gibco, South America) in a humidified in-
cubator with 5% CO2 at 37 °C. The culture medium was renewed every
other day.
After sterilization at 121 °C for 30min (LDZX-30KBS, Shen an,
China), the scaffolds (with a thickness of about 1mm and a diameter of
15mm) were placed into 24-well culture plates, seeded at a cell density
of 1× 104 cells/well, and then incubated in a 5% CO2 incubator at
37 °C. The scaffolds were withdrawn at predetermined time points for
subsequent characterizations.
2.4.2. Cell proliferation
The cell proliferation was evaluated by Cell Counting Kit-8 (CCK8)
assay. The sterilized scaffolds were pre-soaked in DMEM for at least
12 h, followed by incubation in 24-well tissue culture plates for 1, 4,
and 7 days in a 5% CO2 incubator at 37 °C. After transferring the
scaffolds to new 24–well culture plates, 300 μL of medium (containing
CCK8 reagent) was added to each well and then incubated in a 5% CO2
incubator at 37 °C for 3 h. Afterwards, 100 μL of culture medium was
transferred to 96-well plates for the measurement of absorbance at
450 nm using a microplate reader (iMark, Bio Rad, USA).
2.4.3. Cell morphology
After incubation in a 5% CO2 incubator at 37 °C for 4 and 7 days, the
cell-loaded scaffolds were thoroughly rinsed with phosphate buffered
saline (PBS) followed by staining with live staining reagent (Fluorescein
diacetate) for 3min. The stained cultures were observed using a
fluorescence microscope (TS2, Nikon, Japan) and confocal laser scan-
ning microscopy (CLSM, TCS SP8, Leica, Germany). The cytoskeletons
and nuclei of the MCF-7 cells attached on the scaffolds were stained
with rhodamine phalloidin (Molecular Probe, Sigma–Aldrich) and 4’,6-
diamidino-2-phenylindole dihydrochloride (DAPI, Molecular Probe,
Sigma–Aldrich), respectively to assess cell clusters and spreading using
the fluorescence microscope mentioned above.
For SEM observation, cells (after incubation in a 5% CO2 incubator
at 37 °C for 4 and 7 days) were fixed with 2.5% glutaraldehyde solution
at 4 °C for 12 h, and then dehydrated in a graded series of ethanol (50,
60, 70, 80, 90, 95, and 100%), coated with a layer of gold, and observed
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by SEM (FEI Nano 430).
2.4.4. Antiproliferative effect of anticancer drugs
A doxorubicin (DOX) solution was first prepared with deionized
water. After cell seeding at a density of 1× 105 cells/well for 24 h, the
culture medium mentioned above was removed and replaced with 5mL
of drug-containing medium (drug concentration 20mg/mL). 24 h after
drug addition, the cell proliferation CCK8 assay determination was
performed as described above.
2.5. Statistical analysis
The experimental data obtained from at least three independent
experiments was analyzed using an SPSS system. The mean values and
standard deviations (SD) were reported and a p-value of less than 0.05
was considered statistically significant.
3. Results and discussion
3.1. Characterizations of CA/BC scaffold
The morphologies of pristine BC nanofibrous scaffold, electrospun
CA submicrofibrous scaffold, and CA/BC nano-submicrofibrous scaffold
are shown in Fig. 1. Fig. 1a reveals a typical 3D interconnected porous
structure with an average fiber diameter of 49.4 ± 1.2 nm (inset in
Fig. 1a). In the case of electrospun CA submicrofibrous scaffold, a
porous structure consisting of larger fibers with an average diameter of
780.4 ± 10.6 nm is observed (Fig. 1b and inset). As expected, CA/BC
nano-submicrofibrous scaffold shows the homogeneous distribution of
BC nanofibers and CA submicrofibers both on the surface (Fig. 1c) and
in the cross-section (Fig. 1d). In addition, the CA/BC scaffold shows an
interpenetrated and entangled structure, which might be beneficial to
the improvement of mechanical strength of the CA/BC scaffold. The
SEM results confirm that the combined method of in situ biosynthesis
and electrospun is an effective approach to fabricate the nano-sub-
microfibrous scaffold.
Tensile properties of BC, CA, and CA/BC scaffolds are presented in
Table 1. Interestingly, CA/BC scaffold exhibits a higher tensile strength
(0.80 ± 0.01MPa) than BC (0.64 ± 0.02MPa) and CA scaffolds
(0.71 ± 0.05 MPa). In addition, CA/BC also exhibits a higher tensile
modulus (11.10 ± 0.51MPa) than BC (8.30 ± 0.53MPa), but similar
to that of CA scaffold (10.35 ± 0.44MPa). Note that the CA/BC scaf-
fold shows a lower strain at break (17.3 ± 0.7%) than BC
(25.7 ± 0.6%) although it is slightly higher than CA (16.4 ± 0.6%).
The improved mechanical strength and modulus are due to the me-
chanical entanglement between BC nanofibers and CA submicrofibers,
as commonly observed for entangled fiber network [28,29].
Porosity is a very important parameter for scaffolds [30]. The por-
osity values measured in this work are displayed in Fig. 2. Porosities of
BC, CA, and CA/BC are 94.55 ± 1.32%, 87.03 ± 1.63%, and
91.93 ± 2.17%, respectively. The porosity of CA/BC lies between BC
and CA and is larger than 90%, which is a favorable value for cell in-
growth [31]. Fig. 2b–d shows the distribution of pore size of BC, CA,
and CA/BC. As expected, BC has small pores ranging from 2 to 32 μm
with most pores smaller than 10 μm (Fig. 2b) and CA exhibits larger
pores varying from 10 to 85 μm mostly around 40 μm (Fig. 2c). It is
noted that the pore size of CA/BC changes in a wide range of 6–58 μm
with dominant pores at 6–32 μm (Fig. 2d).
In this work, the contact angles of BC, CA, and CA/BC materials
were measured. As shown in Fig. 2e, CA exhibits an average contact
angle of 123.6° while BC shows a low contact angle of 34.5°. The large
value of CA, which was also reported by other researchers [32,33], is
due to its acetylation and the low contact angle of BC is related to the
large amount of surface hydroxyl groups on its surface. Interestingly,
CA/BC shows an average value of 43.4°. The significantly lower value
of CA/BC than CA can be explained by the purification of CA/BC in
Fig. 1. SEM images of BC (a), CA (b), and CA/BC (c) scaffolds. (d) Cross-sectional morphology of CA/BC scaffold. Insets show fiber diameter distribution.
Table 1
Tensile properties of BC, CA, and CA/BC scaffolds.
Materials Tensile strength (MPa) Tensile modulus (MPa) Strain at break (%)
BC 0.64 ± 0.02 8.30 ± 0.53 25.7 ± 0.6
CA 0.71 ± 0.05 10.35 ± 0.44 16.4 ± 0.6
CA/BC 0.80 ± 0.01 11.10 ± 0.51 17.3 ± 0.7
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NaOH solution which leads to deacetylation of CA.
3.2. Cell studies
To compare the cell proliferation on BC, CA, and CA/BC scaffolds,
quantitative CCK8 assay was performed. Fig. 3 presents the absorbance
as a function of culture time. It is found that MCF-7 cells cultured on
each scaffold demonstrate robust proliferation during the incubation
period of up to 7 days. Comparisons among them reveal a significantly
higher absorbance of CA/BC than BC (p < 0.01) and CA (p < 0.01)
scaffolds, which indicates that the nano-submicrofibrous structure of
CA/BC scaffold is more favorable for the proliferation of MCF-7 cells.
Cells are observed by fluorescent microscopy. As shown in Fig. 4, a
progressive increase in the number of viable cells and size of cell ag-
gregates over the experimental period of 7 days is observed. This sug-
gests good biocompatibility of BC, CA, and CA/BC scaffolds. It is clearly
seen that more cells are observed on CA/BC than BC and CA scaffolds at
days 4 and 7, consistent with the CCK8 result.
Fluorescence microscopy was also used to observe the cell ad-
herence after labeling the cytoskeletons with rhodamine phalloidin and
the cell nuclei with DAPI (Fig. 5). Note that MCF-7 cells attach well on
BC, CA, and CA/BC scaffolds and formation of cell clusters is noted,
suggesting that the three scaffolds can provide favorable micro-
environment for growth and proliferation of MCF-7 cells. Similar to
Figs. 4 and 5 shows larger cell clusters on CA/BC scaffold compared to
BC or CA scaffold. In other words, the combination of BC nanofibers
and CA submicrofibers greatly improves the cell compatibility com-
pared to BC or CA scaffold, consistent with the CCK8 and live staining
results.
To further observe the cell morphology, SEM observation was
conducted after 4 and 7 days of culture. Fig. 6 reveals obvious time-
Fig. 2. (a) Porosities of BC, CA, and CA/BC scaffolds. (b–d) Pore size distribution of BC (b), CA (c) and CA/BC (d) scaffolds. (e) Water contact angles of BC, CA, and
CA/BC materials.
Fig. 3. Proliferation of MCF-7 cells cultured on BC, CA, and CA/BC scaffolds.
The values are expressed as mean ± SD. Significance was defined as
*p < 0.05 or **p < 0.01. n= 9 in each group.
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dependent cell cluster growth on each scaffold as well as formation of
protrusions on CA and CA/BC scaffolds. Furthermore, CA/BC scaffold
shows enhanced cell proliferation over BC or CA scaffold.
To determine the penetration of MCF-7 cells into the scaffolds, laser
scanning confocal microscopy was used. As seen in Fig. 7, numerous
cells are noted inside CA and CA/BC scaffolds while limited cells are
inside the BC scaffold. Thus, in addition to providing a biomimetic
architecture, the interpenetrated fiber system allows the 3D culture of
cells, unlike the BC-only scaffold, which is not porous enough as to
allow cell ingrowth, as shown in Fig. 2.
The antiproliferative effect of DOX on cancer cells seeded on dif-
ferent scaffolds is displayed in Fig. 8. The cytotoxic effect of DOX was
monitored 24 h after drug addition. The MCF-7 cells on CA/BC scaffold
are more resistant to DOX as compared to CA or BC scaffold, the cells
grown on BC showing the least resistance. The higher resistance to
DOX, which has been reported by many researchers for many types of
cancer cells [34–36], suggests that cells grown on the CA/BC scaffold
bear closer resemblance to in vivo microenvironment. It is believed that
the structural architecture in the interpenetrated CA/BC scaffold in-
creases cell–cell and cell–matrix interactions, which allowing the 3D
proliferation, altogether contributing to drug resistance generation
[34,36,37]. Therefore, the cultivation of cancer cells on CA/BC scaffold
provides a better model for the evaluation of the cytotoxic effect of
DOX.
Human cancer is a 3D structure consisting of ECM, neighboring
cells, and blood vessels. It is accepted that the biophysical properties of
ECM have a major impact on cancer cell survival, morphogenesis, in-
vasion, and metastasis [38,39]. In recent years, more and more cancer
biologists recognize the limitations of traditional 2D culture substrates
like tissue culture polystyrene and glass in translating the conclusions of
in vitro 2D studies to actual in vivo processes. Therefore, to mimic their
surrounding environment, cancer cell culture on 3D scaffolds has at-
tracted intensive research efforts [40–42]. However, little attention has
been paid on the control of the accurate architecture of natural ECM. In
a previous study, two types of poly(ε-caprolactone) (PCL) fiber mats
with different orientations were fabricated by electrospinning tech-
nique to study the influence of contact cue guidance on breast cancer
cell behavior [43]. However, no studies reported so far addressed the
design of hierarchical structure of scaffolds. In this work, we have
created a novel nano-submicrofibrous scaffold which is closer to natural
ECM than single nanofibrous BC or submicrofibrous CA counterpart.
Different cell attachment and proliferation are observed when MCF-7
cancer cells are cultured on scaffolds with different fiber structures. The
cancer cells on the nano-submicrofibrous CA/BC scaffold show en-
hanced growth of clusters over single nanofibrous BC or sub-
microfibrous CA counterpart. This is understandable since according to
the “contact guidance” theory, cells respond to the geometric cues by
adjusting their cytoskeleton, and finally altering their gene and protein
expressions [43,44]. Indeed, the porosities and wettability are different
among BC, CA, and CA/BC scaffolds. For example, BC is more hydro-
philic than CA/BC while CA has more large pores than CA/BC. How-
ever, these competing factors mitigate the contributions of single BC
and CA scaffolds to the promoted cancer cell behavior. Therefore, we
believe that the biomimetic architecture of CA/BC scaffold plays a
dominant role in enhancing the growth and proliferation of MCF-7 cells
although future investigation is required to determine the accurate role
of each parameter.
Interestingly, the preliminary drug sensitivity tests have proven that
the cancer cells cultured on the nano-submicrofibrous CA/BC scaffold
demonstrate significantly more resistance to DOX. Although it is not
clear whether the hierarchical architecture can affect the cancer inva-
sion and metastasis, our data has clearly demonstrated that the nano-
submicrofibrous CA/BC scaffold can directly control the chemsensi-
tivity of cancer cells to drugs, which is critical in drug screening.
Therefore, engineering a more biomimetic architecture of in vitro
Fig. 4. Live staining micrographs of MCF-7 cells after 1, 4, and 7 days' culture
on BC, CA, CA/BC scaffolds. Scale bar= 100 μm.
Fig. 5. Microscopic images of MCF-7 cells after
proliferation for 4 (a) and 7 (b) days on BC, CA,
and CA/BC scaffolds. Fluorescent staining was
performed with DAPI (blue, top row) and rhoda-
mine phalloidin (red, middle row) for nuclei and
cytoskeletons, respectively. The bottom row is the
result of merging the top and middle rows (Scale
bar= 100 μm).
Fig. 6. SEM images of MCF-7 cells after 4 and 7 days of incubation on BC, CA,
and CA/BC scaffolds.
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models is more effective for assessing the efficacy of anti-cancer drugs.
4. Conclusions
A novel nano/submicrofibrous CA/BC scaffold has been successfully
fabricated by the combined electrospinning and modified in situ bio-
synthesis strategy. The BC fibers had an average diameter of 49 nm
(close to the lower limit of natural collagen fibers) and the electrospun
CA fibers showed an average diameter of 790 nm (comparable to the
upper limit of natural collagen fibers). SEM observation revealed the
close entanglement between CA and BC fibers, which led to improved
mechanical properties of CA/BC scaffold over single BC or CA scaffold.
More importantly, cell proliferation studies showed the greatest cell
growth in the CA/BC scaffold among three scaffolds. Furthermore, SEM
observation proved that the CA/BC scaffold could promote the forma-
tion of cancer cell clusters, suggesting it is the most favorable micro-
environment for growth and proliferation of MCF-7 cells. Finally, the
cancer cells in the CA/BC scaffold were less sensitive to the anticancer
drug than single CA and BC scaffolds which makes it more promising
for in vitro screening of anticancer drugs.
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